FGBI First Guaranty Bancshares, Inc. Insider Trading

Director Marshall T Reynolds bought 109,051 shares of FGBI at $9.17 on 2026-04-30 ($999,997.67 total), raising holdings to 117,551 shares (+1283.0%).

Marshall T Reynolds, a Director, purchased 109,051 shares on 2026-04-30 at $9.17, a substantial $999,997.67 commitment that increased his post-transaction holdings from 8,500 shares to 117,551 shares. At the current price of $10.66, the stock is -1.8% from its 52-week high of $10.86 but has appreciated +17.1% over the past 30 days and +28.1% over 90 days. However, Reynolds' prior trades at FGBI show mixed outcomes: of his 5 prior purchases at this ticker, only 1 was well-timed at the 90-day mark (30d returns ranged from -17.5% to +56.1%, with 90d returns from -35.5% to +50.4%). The company's recent profitability is concerning—while current net income is reported as $2,743,000.00, the company was unprofitable over its most recent full fiscal year, creating uncertainty around sustainability. The timing of this large acquisition coincides with recent stock strength, but the uneven track record of prior purchases at this ticker and the company's full-year losses warrant caution.

Director Edgar R. Iii Smith bought 109,051 shares of FGBI at $9.17; 4 of 4 prior buys at this ticker were well-timed at the 90-day mark.

Director Edgar R. Iii Smith purchased 109,051 shares (109.1K shares) at $9.17 on 2026-04-30, increasing his holdings by 16.1% to 784,400 shares. His prior trading history at FGBI shows a strong pattern of timing: all 4 prior measurable buys achieved positive 90-day returns (ranging from +50.4% to +91.3%), indicating a consistent ability to accumulate shares ahead of price appreciation. His cross-ticker track record further supports this pattern, with 14 prior buys delivering an average 90-day return of +33.1% and a 69.23% win rate. However, this bullish signal is tempered by company fundamentals: FGBI was unprofitable over its most recent full fiscal year, and current market performance (stock up 17.1% over 30 days and 28.1% over 90 days) suggests material price momentum already underway rather than a contrarian or value-based accumulation.

FGBI Director McAnally buys 109,051 shares at $9.17 for $1,000.0K; 2 other insiders also bought within 14 days, cluster pattern despite unprofitable full fiscal year.

Bruce McAnally, a director, acquired 109,051 shares at $9.17 on 2026-04-30 for $1,000.0K, increasing his holdings to 441,587 shares (+32.8% vs pre-transaction). This purchase coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. While the stock has appreciated 17.1% over the past 30 days and 28.1% over 90 days, McAnally's same-ticker track record at FGBI shows mixed timing outcomes—only 1 of 4 prior buys yielded positive 90-day returns. Notably, the company was unprofitable over its most recent full fiscal year despite current net income of $2.7M, introducing fundamental uncertainty about the durability of recent price momentum.

Director Marshall Reynolds buys 46,297 shares of FGBI at $5.40; stock down 52.9% from 52-week high amid -$45.0M net loss.

Director Marshall Reynolds purchased 46,297 shares at $5.40 on 2025-12-31, increasing his holdings to 1,993,821 shares. The transaction occurs with FGBI trading 52.9% below its 52-week high of $11.43, while the company reported net income of -$45,003,000.00. His prior buy at FGBI on 2025-09-30 declined 35.5% over 90 days, and across his three previous FGBI purchases, none achieved positive returns at the 90-day mark, suggesting a pattern of ill-timed entry points at this ticker. The cluster pattern—with 2 other insiders also buying within the past 14 days—indicates coordinated buying activity, though the persistent underperformance in his own trade history and the company's substantial net loss warrant careful evaluation of whether this reflects informed conviction or reactive positioning.

Director Smith Edgar R. III buys 208,996 shares of FGBI at $5.40 on 2025-12-31, raising stake 63.7%; concurrent cluster buy and negative fundamentals warrant attention.

Smith Edgar R. III purchased 208,996 shares at $5.40, increasing his holdings from 328,270 shares to 537,266 shares—a 63.7% increase in his position. The stock is currently trading at $5.38, down 52.9% from its 52-week high of $11.43 and down 39.0% over the past 90 days, despite a near-term 5.9% gain over the past 30 days. At the same-ticker level, Smith has completed four prior purchases on 2025-11-20 and one on 2025-11-17, with 30-day returns ranging from 1.8% to 5.2%, though one prior buy on 2025-11-17 returned -12.3% at the 30-day mark. The company reported net income of -$45,003,000.00, and this buy occurred as part of a cluster pattern with two other insiders purchasing within the past 14 days. The scale of accumulation, combined with negative earnings and multi-insider buying activity, suggests material consideration of value at current depressed price levels, though the stock's steep decline from recent highs and negative profitability create offsetting risks.

Director McAnally buys 92.6K shares of FGBI at $5.40 (+44.6% of holdings); stock down -52.9% from 52-week high, fundamentals weak ($-45.0M net income).

Bruce McAnally, a Director, purchased 92,600 shares at $5.40 on 2025-12-31, increasing holdings by 44.6% to 300,360 shares total. This represents a substantial position increase at a price $0.02 below current levels ($5.38), yet the stock is trading -52.9% from its 52-week high of $11.43. The company's fundamentals show net income of $-45,003,000.00 and a depressed market cap of $82,598,854.86. Notably, two other insiders also purchased shares within the past 14 days, forming a cluster buy pattern. However, McAnally's own track record at this ticker has been unfavorable: his three prior FGBI purchases showed 90-day results of -35.5%, -0.4%, and -4.7%, with a 0% win rate at the 90-day mark, suggesting a pattern of ill-timed entry decisions at this specific stock.

Director Walker buys 5,745 FGBI shares at $4.53 amid -63.5% 52-week decline and -$45.0M net loss

Walker Robert W, Director, purchased 5,745 shares at $4.53 on 2025-12-11, increasing his holdings to 51,121 shares (+12.7% from prior level of 45,376 shares). This buy occurs against deteriorating stock fundamentals: the company reported net income of -$45,003,000.00, the stock is down -63.5% from its 52-week high of $13.39, and the current price of $4.89 reflects a -14.5% decline over the past 30 days. Walker's own same-ticker transaction history at FGBI shows a 0% well-timed rate on prior buys—his earlier purchases on 2025-09-11 and 2025-08-28 posted -45.2% and -39.8% 90-day returns respectively—establishing a pattern of poorly-timed entries at this stock. His cross-ticker track record reinforces this pattern: 10 prior open-market buys averaged -25.1% over 90 days with a 0.00% win rate. This purchase appears to follow immediately after another buy on 2025-12-10, suggesting continued accumulation despite deteriorating near-term price action and a long-established pattern of trades that underperform over the measurable period.

Director Walker buys 7,500 FGBI shares at $4.54; stock now $4.70, down 66.7% from 52-week high

WALKER ROBERT W purchased 7,500 shares at $4.54 on 2025-12-10, increasing his holdings to 45,376 shares—a 19.8% increase from his 37,876 share pre-transaction baseline. The current price of $4.70 is -22.8% over the last 30 days and -42.3% over the last 90 days, reflecting a stock in distress and trading at -66.7% from its 52-week high of $14.13. Notably, the company posted net income of -$45,003,000, indicating significant losses, and the purchase occurred amid a dramatic price collapse. Across Walker's cross-ticker history, his 10 prior buy trades averaged -25.1% over 90 days with a 0.00% win rate, and at FGBI specifically, his two measurable prior buys (2025-09-11 and 2025-08-28) produced 90-day returns of -45.2% and -39.8% respectively, with zero of two prior buys at this ticker well-timed at the 90-day mark. This latest purchase, following three additional buys in the past month at FGBI, coincides with sustained operational losses and sustained price pressure.

Director Walker bought 3,600 shares at blended $4.94 across 2 transactions; stock now -70.1% from 52-week high amid $-45.0M net loss.

Walker Robert W, a director at First Guaranty Bancshares, made 2 separate purchases totaling 3,600 shares for $17,784.00 at an average price of $4.94 on November 25 and December 4, 2025, increasing his holdings by +10.5% to 37,876 shares. The current price of $4.41 stands 70.1% below the 52-week high of $14.75, and the stock has declined 23.6% over 30 days and 48.5% over 90 days. Across his prior 5 trades at FGBI, Walker's timing at the 90-day mark has been uniformly unsuccessful: all 4 measurable prior buys at this ticker posted negative 90-day returns ranging from -0.4% to -39.8%, establishing a 0% 90-day win rate at FGBI. The company reports a net loss of $-45,003,000.00, further context that the purchase occurs amid material financial deterioration rather than operational strength.

Director Smith Edgar R. III bought 21,300 shares of FGBI at blended average $5.00 in 5 transactions on Nov 17-20, amid -65.4% decline from 52-week high and -45.0M net income.

Smith Edgar R. III, a director, executed 5 separate purchases totaling 21,300 shares for $106,480.00 between November 17–20, 2025, at prices ranging from $4.81 to $5.78 and a blended average of $5.00. The transactions increased his holdings by 6.7%, from 320,137 to 341,437 shares. The purchases occur against a backdrop of significant headwinds: the stock has declined 65.4% from its 52-week high of $14.75 and 36.2% over the past 30 days, while the company reported net income of -$45,003,000.00 and trades at a P/E ratio of 6.30. His same-ticker history shows mixed timing: 2 of 4 prior measurable buys at FGBI produced positive 90-day returns (April 2 and April 3 trades), while 2 of 4 produced negative 90-day returns (May 12 and September 30 trades). The accumulation during a period of steep price deterioration and negative earnings warrants close attention to whether it reflects conviction or reflects constraints—without additional context on composition or transaction flags, the characterization remains ambiguous.